Cronos (CRON) Non Operating Investment Income (2019 - 2024)
Cronos (CRON) recorded quarterly Non Operating Investment Income of -$18000.0 in Q1 2024, up 74.65% quarter-over-quarter from -$71000.0 in Q4 2023, and up 72.31% on a YoY basis from -$10446.4 in Q2 2023.
Cronos (CRON) Non Operating Investment Income (2019 - 2024) Analysis & Trends
Cronos' Non Operating Investment Income history runs 6 years deep, the most recent figure standing at -$18000.0 for Q1 2024.
- In Q1 2024, Non Operating Investment Income rose 72.31% year-over-year to -$18000.0; the TTM figure through Mar 2024 stood at -$38000.0 (down 101.06% YoY), while the FY2024 annual figure was $49000.0, up 157.65% from the prior year.
- Non Operating Investment Income was -$18000.0 for Q1 2024 at Cronos, up from -$71000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $132.9 million in Q3 2021 to a low of -$116.9 million in Q1 2021.
- Historically, Non Operating Investment Income has averaged $17.3 million across 5 years, with a median of $43000.0 in 2023.
- Biggest YoY gain for Non Operating Investment Income was 421.2% in 2021; the steepest drop was 203.09% in 2021.
- A 5-year view of Non Operating Investment Income shows it stood at -$53.5 million in 2020, then surged by 137.49% to $20.1 million in 2021, then tumbled by 100.72% to -$144000.0 in 2022, then soared by 50.69% to -$71000.0 in 2023, then jumped by 74.65% to -$18000.0 in 2024.
- The last three Non Operating Investment Income figures came in at -$18000.0 (Q1 2024), -$71000.0 (Q4 2023), and $8000.0 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -18,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Dec 31, 2023 | -71,000.00 |
| Dec 31, 2023 | -71,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | -65,000.00 |
| Mar 31, 2023 | -65,000.00 |
| Dec 31, 2022 | -144,000.00 |
| Dec 31, 2022 | -144,000.00 |
| Sep 30, 2022 | 375,000.00 |
| Sep 30, 2022 | 375,000.00 |
| Jun 30, 2022 | 3.41 Mn |
| Jun 30, 2022 | 3.41 Mn |
| Mar 31, 2022 | 10.42 Mn |
| Mar 31, 2022 | 10.42 Mn |
| Dec 31, 2021 | 20.07 Mn |
| Dec 31, 2021 | 20.07 Mn |